Bayesian Capital Management, LP Ironwood Pharmaceuticals Inc Transaction History

Bayesian Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $139,380 - $160,080	13,800 New	13,800 $146,000
Q2 2022 Aug 15, 2022	SELL	$11.05 - $12.72 $608,855 - $700,872	-55,100 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.61 - $12.88 $584,611 - $709,688	55,100 New	55,100 $693,000
Q2 2020 Aug 14, 2020	SELL	$9.14 - $11.97 $192,854 - $252,567	-21,100 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.58 - $14.01 $80,652 - $131,694	9,400 Added 80.34%	21,100 $213,000
Q4 2019 Feb 14, 2020	BUY	$8.22 - $14.0 $96,174 - $163,800	11,700 New	11,700 $156,000

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $679M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.